Cargando…

The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease

BACKGROUND: Patients with end-stage renal disease are more likely to suffer cognitive impairment. Cognitive impairment may lead to long-term severe adverse consequences. PURPOSE: To explore the impact of different blood purification therapy on cerebral blood flow and cognitive functions in end-stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoyan, Chen, Xiaohui, Tang, Yuting, Zhang, Liuping, Wang, Yue, Hou, Zhenghua, Jang, Wenhao, Yuan, Yonggui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892756/
https://www.ncbi.nlm.nih.gov/pubmed/36741052
http://dx.doi.org/10.3389/fnins.2022.980658
_version_ 1784881383744733184
author Wang, Xiaoyan
Chen, Xiaohui
Tang, Yuting
Zhang, Liuping
Wang, Yue
Hou, Zhenghua
Jang, Wenhao
Yuan, Yonggui
author_facet Wang, Xiaoyan
Chen, Xiaohui
Tang, Yuting
Zhang, Liuping
Wang, Yue
Hou, Zhenghua
Jang, Wenhao
Yuan, Yonggui
author_sort Wang, Xiaoyan
collection PubMed
description BACKGROUND: Patients with end-stage renal disease are more likely to suffer cognitive impairment. Cognitive impairment may lead to long-term severe adverse consequences. PURPOSE: To explore the impact of different blood purification therapy on cerebral blood flow and cognitive functions in end-stage renal disease. MATERIALS AND METHODS: This prospective study evaluated patients with end-stage renal disease undergoing blood purification from January to March 2021. Matched healthy controls were also included. Participants performed neurocognitive measurements, including a mini-mental state examination, logical memory test-20-minutes delayed, verbal fluency test, digit span test, clock drawing test, and stroop color and word test C. In addition, we tested plasma amyloid-β protein levels, serum Fe and hemoglobin levels in blood samples. Cerebral blood flow was measured using pulsed pseudocontinuous arterial spin labeling. We analyzed and compared the correlation between cognitive function, biomarkers, and cerebral blood flow between patients and healthy subjects, as well as between patients with different treatments. RESULTS: A total of 44 patients with end-stage renal disease (mean age, 57.39 years ± 8.63) and 46 healthy controls (mean age, 56.15 years ± 6.40) were recruited. Patients receive hemodialysis three times a week, and 27 of them have been replaced hemodialysis for hemodiafiltration twice a month. The cognitive function of patients was worse than healthy controls (P < 0.05). The patients showed higher plasma concentrations of amyloid-β40, amyloid-β42, Tau, and pTau181 than healthy controls (P < 0.05). The group receiving both hemodialysis and hemodiafiltration had higher cerebral blood flow signal values in the left caudate nucleus (chuster-level P < 0.05, voxel-level P < 0.001). They also exhibited better verbal fluency function than the hemodialysis-only group (P < 0.05). CONCLUSION: Patients with the end-stage renal disease showed widespread cognitive declines. Cerebral blood flow generally decreased in the cerebral cortex and increased in subcortical regions. The hemodiafiltration may protect verbal function by increasing cerebral blood flow in the left caudate.
format Online
Article
Text
id pubmed-9892756
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98927562023-02-03 The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease Wang, Xiaoyan Chen, Xiaohui Tang, Yuting Zhang, Liuping Wang, Yue Hou, Zhenghua Jang, Wenhao Yuan, Yonggui Front Neurosci Neuroscience BACKGROUND: Patients with end-stage renal disease are more likely to suffer cognitive impairment. Cognitive impairment may lead to long-term severe adverse consequences. PURPOSE: To explore the impact of different blood purification therapy on cerebral blood flow and cognitive functions in end-stage renal disease. MATERIALS AND METHODS: This prospective study evaluated patients with end-stage renal disease undergoing blood purification from January to March 2021. Matched healthy controls were also included. Participants performed neurocognitive measurements, including a mini-mental state examination, logical memory test-20-minutes delayed, verbal fluency test, digit span test, clock drawing test, and stroop color and word test C. In addition, we tested plasma amyloid-β protein levels, serum Fe and hemoglobin levels in blood samples. Cerebral blood flow was measured using pulsed pseudocontinuous arterial spin labeling. We analyzed and compared the correlation between cognitive function, biomarkers, and cerebral blood flow between patients and healthy subjects, as well as between patients with different treatments. RESULTS: A total of 44 patients with end-stage renal disease (mean age, 57.39 years ± 8.63) and 46 healthy controls (mean age, 56.15 years ± 6.40) were recruited. Patients receive hemodialysis three times a week, and 27 of them have been replaced hemodialysis for hemodiafiltration twice a month. The cognitive function of patients was worse than healthy controls (P < 0.05). The patients showed higher plasma concentrations of amyloid-β40, amyloid-β42, Tau, and pTau181 than healthy controls (P < 0.05). The group receiving both hemodialysis and hemodiafiltration had higher cerebral blood flow signal values in the left caudate nucleus (chuster-level P < 0.05, voxel-level P < 0.001). They also exhibited better verbal fluency function than the hemodialysis-only group (P < 0.05). CONCLUSION: Patients with the end-stage renal disease showed widespread cognitive declines. Cerebral blood flow generally decreased in the cerebral cortex and increased in subcortical regions. The hemodiafiltration may protect verbal function by increasing cerebral blood flow in the left caudate. Frontiers Media S.A. 2023-01-19 /pmc/articles/PMC9892756/ /pubmed/36741052 http://dx.doi.org/10.3389/fnins.2022.980658 Text en Copyright © 2023 Wang, Chen, Tang, Zhang, Wang, Hou, Jang and Yuan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Wang, Xiaoyan
Chen, Xiaohui
Tang, Yuting
Zhang, Liuping
Wang, Yue
Hou, Zhenghua
Jang, Wenhao
Yuan, Yonggui
The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
title The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
title_full The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
title_fullStr The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
title_full_unstemmed The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
title_short The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
title_sort impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892756/
https://www.ncbi.nlm.nih.gov/pubmed/36741052
http://dx.doi.org/10.3389/fnins.2022.980658
work_keys_str_mv AT wangxiaoyan theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT chenxiaohui theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT tangyuting theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT zhangliuping theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT wangyue theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT houzhenghua theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT jangwenhao theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT yuanyonggui theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT wangxiaoyan impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT chenxiaohui impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT tangyuting impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT zhangliuping impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT wangyue impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT houzhenghua impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT jangwenhao impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease
AT yuanyonggui impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease